Top Markets
#1 TENDIES TENDIES +60.89%
#2 Threshold Network Threshold Network +54.06%
#3 Cash Cat Cash Cat +21.98%
#4 OSK OSK +16.53%
#5 Kinetiq Kinetiq +16.42%
#6 Mubarak Mubarak +13.34%
#7 Maple Finance Maple Finance +13.30%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Magma Finance Magma Finance +12.08%
#10 Kite Kite +11.50%
Coin of the day
TENDIES TENDIES
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Hisse Senetlerindeki Sıralama #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Hisse Fiyatı
$1.38
Piyasa Değeri
$255.69M
Değişim (1 gün)
3.76%
Değişim (1 yıl)
-20.69%
Ülke
US
Ticaret Neumora Therapeutics, Inc. Common Stock (NMRA)

Kategori

Healthcare
Neumora Therapeutics, Inc. Common Stock (NMRA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.36 - 2026-09-01

Gün sonu en düşük fiyat: $12.50 - 2023-09-01
Neumora Therapeutics, Inc. Common Stock için hisse fiyatı geçmişi: 2023 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $554.82 38.36%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.67%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.77 515.03%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.39 8.87%
CH